Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Comparative bioavailability study of two phenoxymethylpenicillin potassium tablet formulations in healthy volunteers.

Moreno RA, Boldrina L, Guermani A, Mazucheli J, Sverdloff C, Borges NC.

Int J Clin Pharmacol Ther. 2007 Dec;45(12):669-76.

PMID:
18184536
2.
3.

Comparative pharmacokinetic and bioequivalence study of azithromycin 500 mg tablet in healthy Bangladeshi volunteers.

Ahmed MU, Islam MS, Shohag H, Karim R, Mustafa AG, Bhuiyan NH, Rahim M, Hasnat A.

Int J Clin Pharmacol Ther. 2012 Jun;50(6):452-8.

PMID:
22677307
5.

Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.

Palma-Aguirre JA, Absalón-Reyes JA, Novoa-Heckel G, de Lago A, Oliva I, Rodríguez Z, González-de la Parra M, Burke-Fraga V, Namur S.

Clin Ther. 2007 Jun;29(6):1146-52.

PMID:
17692728
6.

Comparative bioavailability of two dexamethasone tablet formulations in Indonesian healthy volunteers.

Harahap Y, Sasongko L, Prasaja B, Indriati E, Lusthom W, Lipin.

Arzneimittelforschung. 2009;59(4):191-4. doi: 10.1055/s-0031-1296384.

PMID:
19517895
7.

Bioequivalence study of two commercial amoxicillin suspension formulations in healthy human volunteers.

Franco GC, Baglie S, Ruenis AP, Franco LM, Cogo K, Oshima-Franco Y, Silva P, Groppo FC, Rosalen PL.

Int J Clin Pharmacol Ther. 2014 May;52(5):425-30. doi: 10.5414/CP202039.

PMID:
24755132
11.

Comparative bioavailability study of two cefixime formulations administered orally in healthy male volunteers.

Zakeri-Milani P, Valizadeh H, Islambulchilar Z.

Arzneimittelforschung. 2008;58(2):97-100. doi: 10.1055/s-0031-1296475.

PMID:
18412024
12.

Bioequivalence and pharmacokinetics of two 10-mg bisoprolol formulations as film-coated tablets in healthy white volunteers: a randomized, crossover, open-label, 2-period, single-dose, fasting study.

Bus-Kwasnik K, Ksycinska H, Les A, Serafin-Byczak K, Rudzki PJ, Raszek J, Lazowski T, Bielak A, Wybraniec A.

Int J Clin Pharmacol Ther. 2012 Dec;50(12):909-19. doi: 10.5414/CP201726.

PMID:
23006443
13.
14.

Comparative bioavailability of 875 mg amoxicillin tablets in healthy human volunteers.

Baglie S, Rosalen PL, Franco LM, Ruenis AP, Baglie RC, Franco GC, Silva P, Groppo FC.

Int J Clin Pharmacol Ther. 2005 Jul;43(7):350-4.

PMID:
16035378
15.

Metronidazole immediate release formulations: a fasting randomized open-label crossover bioequivalence study in healthy volunteers.

de Freitas Silva M, Schramm SG, Kano EK, Koono EE, Manfio JL, Porta V, dos Reis Serra CH.

Arzneimittelforschung. 2012 Oct;62(10):490-5. doi: 10.1055/s-0032-1321873. Epub 2012 Aug 23.

PMID:
22918856
16.

Bioavailability of two oral formulations of a single dose of levofloxacin 500 mg: an open-label, randomized, two-period crossover comparison in healthy Mexican volunteers.

Galan-Herrera JF, Poo JL, Rosales-Sanchez O, Fuentes-Fuentes E, Cariño L, Burke-Fraga V, Namur S, Parra MG.

Clin Ther. 2009 Aug;31(8):1796-803. doi: 10.1016/j.clinthera.2009.08.004.

PMID:
19808138
17.

Comparative bioavailability of two losartan formulations in healthy human volunteers after a single dose administration.

Oliveira CH, Medeiros Silva R, Santagada V, Caliendo G, Perissutti E, Prado Galuppo M, Marcondes Rezende V, Barrientos-Astigarraga RE, Mendes GD, De Nucci G.

Int J Clin Pharmacol Ther. 2006 Mar;44(3):142-8.

PMID:
16550737
18.

Average bioequivalence of clarithromycin immediate released tablet formulations in healthy male volunteers.

Lohitnavy M, Lohitnavy O, Wittaya-areekul S, Sareekan K, Polnok S, Chaiyaput W.

Drug Dev Ind Pharm. 2003 Jul;29(6):653-9.

PMID:
12889783
19.

Comparative bioavailability of 2 tablet formulations of levodopa/benserazide in healthy, fasting volunteers: a single-dose, randomized-sequence, open-label crossover study.

Keller GA, Czerniuk P, Bertuola R, Spatz JG, Assefi AR, Di Girolamo G.

Clin Ther. 2011 Apr;33(4):500-10. doi: 10.1016/j.clinthera.2011.04.012.

PMID:
21635995
20.

Bioequivalence evaluation of two rosiglitazone tablet formulations.

Yusuf A, Al-Gaai E, Hammami MM.

Arzneimittelforschung. 2006;56(11):740-3.

PMID:
17220051

Supplemental Content

Support Center